A panelist discusses how uncomplicated urinary tract infections (UTIs ... course antibiotics by primary care physicians, while complicated UTIs involve underlying conditions or anatomical ...
Complicated urinary infections companies working in the market are Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, Allecra Therapeutics., and others. LAS VEGAS, NV, UNITED STATES, January 13, ...
(KSP-1007 + meropenem) is under clinical development by Sumitomo Pharma and currently in Phase I for Complicated Intra-Abdominal Infections. According to GlobalData, Phase I drugs for Complicated ...
The declassified report, released on Friday, alleges that the agency's approach has "greatly complicated" the treatment and understanding of the condition, which has affected U.S. personnel and ...
We report four cases of pulmonary mycobacterial disease (three due to Mycobacterium malmoense and one to Myco- bacterium avium intracellulare) complicated by the development of chronic necrotising ...
1 WHO described the previously undiagnosed disease as “acute respiratory infections complicated by malaria,” which had led to an increase in severe infections and death when compounded by acute ...
Royal College of Physicians (1991) 1991–2000 Aggressive treatment, prophylaxis and investigation of all children aged <7 years [81] American Academy of Pediatrics Guideline (1999) Aggressive ...
Fosfomycin disodium is under development for the treatment of complicated urinary tract infections (cUTI), acute pyelonephritis, suspected infection or peri-operative prophylaxis in pediatrics, ...